Literature DB >> 1470227

Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

H Nakaya1, Y Hattori, M Endou, S Gandou, M Kanno.   

Abstract

Since it has been reported that several class I drugs stereoselectively block sodium channels, potassium channels and muscarinic receptors in cardiac tissues, electrophysiologic and anticholinergic effects of enantiomers of pirmenol, a class I antiarrhythmic drug, were examined. Both (+) and (-) pirmenol depressed the maximum upstroke velocity (Vmax) of the action potential in a concentration-dependent manner in guinea-pig papillary muscles driven at 1.0 Hz, and there was no significant difference in the potency of the class I effect between the enantiomers. The onset rates of use-dependent block (UDB) of Vmax at 2.0 Hz for 10 mumol/l (+) and (-) pirmenol were 0.30 +/- 0.03 and 0.29 +/- 0.01 per action potential, and the recovery time constants from UDB for (+) and (-) pirmenol were 27.0 +/- 2.7 and 27.7 +/- 1.9 s, respectively, indicating no difference in the binding and unbinding kinetics to the sodium channel between the enantiomers. Both (+) pirmenol and (-) pirmenol prolonged action potential duration (APD) at low concentrations (1-10 mumol/l) and shortened it at high concentrations (30-100 mumol/l). Again, there was little difference with respect to the effects on APD between the enantiomers. However, in the isolated guinea-pig left atria (-) pirmenol more potently antagonized the negative inotropic effect of carbachol than (+) pirmenol, and the pA2 values for (+) and (-) pirmenol were 6.41 and 6.71, respectively. The functional study was supported by the radioligand binding experiments using [3H]N-methylscopolamine ([3H]NMS) in guinea-pig left atrial membranes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470227     DOI: 10.1007/bf00169013

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation.

Authors:  E A JOHNSON; M G McKINNON
Journal:  J Pharmacol Exp Ther       Date:  1957-08       Impact factor: 4.030

2.  Membrane potential-dependent effects of SC-36602, a new class I antiarrhythmic agent on cardiac action potentials.

Authors:  L E Borowicz; H C Schniepp; M C Sanguinetti
Journal:  J Cardiovasc Pharmacol       Date:  1987-01       Impact factor: 3.105

3.  Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics.

Authors:  C F Starmer; A O Grant; H C Strauss
Journal:  Biophys J       Date:  1984-07       Impact factor: 4.033

4.  Frequency- and voltage-dependent depression of maximum upstroke velocity of action potentials by pirmenol in guinea pig ventricular muscles.

Authors:  H Nakaya; N Tohse; M Kanno
Journal:  Jpn J Pharmacol       Date:  1988-12

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers.

Authors:  R F Reder; P Danilo; M R Rosen
Journal:  Eur J Pharmacol       Date:  1980-02       Impact factor: 4.432

7.  Inhibitory effects of quinidine on rat heart muscarinic receptors.

Authors:  M Waelbroeck; P De Neef; P Robberecht; J Christophe
Journal:  Life Sci       Date:  1984-09-03       Impact factor: 5.037

8.  Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.

Authors:  F Vanhoutte; J Vereecke; E Carmeliet; N Verbeke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

9.  Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry.

Authors:  M J Mirro; A M Watanabe; J C Bailey
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

10.  Stereospecific effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine.

Authors:  G A Kidwell; S F Schaal; W W Muir
Journal:  J Cardiovasc Pharmacol       Date:  1987-03       Impact factor: 3.105

View more
  1 in total

1.  Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.

Authors:  H Uemura; Y Hara; M Endou; K Mori; H Nakaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.